Medical innovation plays a central role in tackling the biggest global health challenges we face and delivering progress toward the 2030 Sustainable Development Goals.

Partnerships between pharmaceutical companies, the broader scientific community, multilateral agencies, and governments are core to our success. These partnerships can range from the development of new medical products to supporting the clinical services needed to improve both individual and public health outcomes – and everything in between.

Our flagship event at the 77^th World Health Assembly will be an opportunity to hear perspectives from leading figures across this community about how these partnerships can go further to deliver meaningful impact for people and healthcare systems around the world.

Program and keynote speakers will be announced soon. For more information, please contact events@ifpma.org.